Home
Leading the World in Natural Product Discovery
About Us › Investors

Investors

Current investors in MerLion include:
  • 3i Group Investment LP
  • Aravis Venture I LP
  • Aurelia Private Equity
  • Brandenburg Capital
  • Bio*One Capital
  • Bioveda Capital
  • Commerce Ventures
  • Heidelberg Capital 
  • JAFCO Asia Pacific
  • Lacuna SICAV Lacuna Apo Biotech Fund
  • Mitsubishi Corporation
  • Nomura Research and Advisory
  • Novartis Venture Fund
  • SBI Bio Life Science Investment
  • Temasek Holdings
  • Venture Incubator
  • Zurcher Kantonalbank.

 

  • Home
  • About Us
    • Who We Are
    • Board of Directors
    • Management
    • Investors
    • Awards
    • The MerLion
  • Research
    • Natural Product Collections
    • Discovery Biology
    • Natural Product Chemistry
    • Bioprocessing
  • Our Services
    • Extract & Compound Supply
      • Pure Compounds
      • Natural Product Supersets
      • Extract Libraries
    • Screening & Assay Development
      • High Throughput Screening
      • Antimicrobial and Cytotoxicity Testing
      • Assay Development
    • Chemistry & Analytical
      • Fractionation of Extracts
      • Isolation of Natural Products
      • Chemical Structure Elucidation
      • Sample Characterisation by HPLC/UV/MS
      • Sample Characterisation by 1H qNMR
      • Chemical Fingerprinting of Extracts
    • Fermentation & Taxonomic
      • Microbial Fermentation
      • Strain and Process Optimisation
      • Molecular Strain Identification
    • Enquiry
  • Development
    • Finafloxacin
    • Programmes for Licensing
  • News & Publications
    • Press Releases
    • Scientific Publications
    • Presentations and Posters
    • Subscribe to News
  • Contact Us

Copyright © 2009 MerLion Pharma. All Rights Reserved.